Article
Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability <i>via</i> overactivation of neuronal GluN2C NMDA receptors
2023-12-02
Abstract excerpt
<h4>Objective</h4> Genetic variations in proteins of the mechanistic target of rapamycin (mTOR) pathway cause a spectrum of neurodevelopmental disorders often associated with brain malformations and with intractable epilepsy. The mTORopathies are characterized by hyperactive mTOR pathway and comprise tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) type II. How hyperactive mTOR translates into...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 57bd73d1-9344-5e3d-961a-87bb6d85c130
- DOI
- 10.1101/2023.12.01.569539
